Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Creatinine2

K-Number: K210452 · 2022-03-22

Decision Date2022-03-22
Product CodeCGX
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Creatinine2 is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Ireland Diagnostics Division. It received FDA 510(k) clearance on 2022-03-22 under 510(k) number K210452. The device is classified under product code CGX. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Creatinine2?

Creatinine2 is a medical device that received FDA 510(k) clearance on 2022-03-22. The listed applicant is Abbott Ireland Diagnostics Division. The 510(k) number is K210452.

When did Creatinine2 receive FDA 510(k) clearance?

Creatinine2 received FDA 510(k) clearance on 2022-03-22, under 510(k) number K210452.

Who is the listed applicant for Creatinine2?

The FDA 510(k) record lists Abbott Ireland Diagnostics Division as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Creatinine2?

The FDA product code for Creatinine2 is CGX.

Other records listing Abbott Ireland Diagnostics Division as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 8 devices →

Related Devices (Code: CGX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.